The 20 Best Minimal Change Disease Doctors in New York, US

Christine Sethna is a Pediatric Nephrologist in Lake Success, New York. Dr. Sethna is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Nephrotic Syndrome, Minimal Change Disease, Focal Segmental Glomerulosclerosis, Hypertension, and Kidney Transplant.

Andrew S. Bomback, MD, MPH, is a nephrologist who specializes in glomerular diseases and resistant hypertension. Dr. Bomback received his undergraduate degree from Harvard University and his medical degree from Columbia University College of Physicians and Surgeons. He completed residency in Internal Medicine and fellowships in Nephrology and Clinical Epidemiology at the University of North Carolina at Chapel Hill, where he was the Doc J. Thurston III Fellow in Nephrology and Hypertension. In 2009, he returned to Columbia University as an associate at the Center for Glomerular Diseases and is currently Assistant Professor of Medicine at Columbia University Medical Center. Dr. Bomback is a member of the ColumbiaDoctors Hypertension Center, a multi-disciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for patients with hypertension,Dr. Bomback has published over 100 peer-reviewed articles and book chapters on the subjects of chronic kidney disease, glomerular diseases, and hypertension. He is the co-author of the textbook, Chronic Kidney Disease and Hypertension Essentials, and an editor of the National Kidney Foundation's Primer on Kidney Diseases. He is the recipient of the 2013 Daniel V. Kimberg Junior Faculty Award for oustanding teaching of medical students and housestaff.Dr. Bomback's research interests focus on evaluating novel therapies for glomerular diseases. He currently serves as principal or co-investigator on clinical trials of new treatments for IgA nephropathy, membranous nephropathy, lupus glomerulonephritis, hereditary nephritis, C3 glomerulopathy, and focal segmental glomerulosclerosis. Dr. Bomback is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Membranoproliferative Glomerulonephritis, Glomerulonephritis, Membranous Nephropathy, Minimal Change Disease, and Kidney Transplant.

Pietro Canetta is a Nephrologist in New York, New York. Dr. Canetta is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Focal Segmental Glomerulosclerosis, Glomerulonephritis, Minimal Change Disease, IgA Nephropathy, and Kidney Transplant. Dr. Canetta is currently accepting new patients.

Howard Trachtman is a Pediatric Nephrologist in New York, New York. Dr. Trachtman is rated as an Elite provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Focal Segmental Glomerulosclerosis, Minimal Change Disease, Glomerulonephritis, Nephrotic Syndrome, and Kidney Transplant.

"Kenar D. Jhaveri, MD, is Professor of Medicine and Associate Chief in the Division of Kidney Diseases and Hypertension at Northwell Health and Zucker School of Medicine at Hofstra/Northwell. He completed his residency training at Yale University New Haven Hospital in Internal Medicine and then a fellowship in Nephrology at New York Presbyterian Hospital-Weill Cornell campus. His clinical interests are in glomerular diseases and onconephrology( cancer and its effect on the kidney). He is the founding member of the American Society of Onconephrology. He is a columnist for the ASN Kidney News for the section called ""Detective Nephron."" His interest in nephrology education is vested in using creative ways of teaching nephrology to medical students, residents, and fellows. He has published on onconephrology, Glomerular diseases, AKI and also in using social media and other innovative tools (games, concept maps, role playing, creative writing) to make nephrology a fun and exciting field. His most recent projects are in learning about renal toxicities of targeted oncological agents, immunotherapies, and COVID related AKI and glomerular diseases.". Dr. Jhaveri is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Glomerulonephritis, Interstitial Nephritis, Low Potassium Level, Low Sodium Level, and Kidney Transplant.

Frederick J. Kaskel, MD, PhD, is involved in basic and clinical investigations into the mechanisms of the major kidney disorders in pediatrics. He is particularly interested in the physiology and pathophysiology of normal and abnormal development and function of the kidneys throughout the critical periods of growth and maturation extending into adolescence and young adulthood. He is actively involved in a clinical trial funded by the National Institutes of Health (NIH) to find the most efficacious therapy for focal segmental glomerulosclerosis, one of the major causes of progressive glomerular disease, while investigating the molecular etiologies for its expression. Another NIH-supported study involves chronic kidney disease in children and how it affects their growth and neurocognitive development, and the risk factors for cardiovascular disease and renal progression. Dr. Kaskel is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease, Metabolic Acidosis, and Kidney Transplant.

"Dr. Ali Gharavi is a kidney specialist with expertise in human genetics. He is the Harold Ames Hatch (II) Professor of Medicine and currently serves as Chair of the Department of Medicine at Columbia University Vagelos College of Physicians and Surgeons, and Physician-in-Chief, NewYork-Presbyterian Hospital/Columbia. He previously served as the Chief of the Division of Nephrology at NewYork-Presbyterian/Columbia University Irving Medical Center.The principal investigator on multiple research projects funded by the National Institutes of Health (NIH), Dr. Gharavi has specific interests in the genetics of kidney diseases, including IgA nephropathy and congenital abnormalities of the kidney and urinary tract. His research has identified genes and risk loci for many kidney diseases and has demonstrated the utility of sequencing for the diagnosis and management of patients with kidney disorders.""Owing to the recent progress in genomic technologies, we now have the opportunity to make a precise genetic diagnosis for many patients and individualize care based on the specific molecular mechanism of disease. My objective is to therefore bring personalized genomic medicine from the laboratory into patient care,"" says Dr. Gharavi. As Department Chair, he aims to enhance access to genomic medicine for patients and reduce disparities for underserved populations.After receiving his medical degree from George Washington University, Dr. Gharavi completed his Internal medicine residency at Mount Sinai Medical Center and fellowships in hypertension and nephrology, also at Mount Sinai. He then completed a postdoctoral fellowship in human genetics at Yale University School of Medicine. He previously held academic appointments at Yale University School of Medicine and Mount Sinai School of Medicine and hospital appointments at Mount Sinai Hospital. Dr. Gharavi is the author of over 200 peer-reviewed publications and has led national and International committees related to genetic testing and research for kidney disorders. He was a recipient of the Judson Daland Prize for Outstanding Clinical Investigation from the American Philosophical Society, the National Kidney Foundation Clinical Scientist Award, and Homer Smith Award from the American Society of Nephrology. He was elected to the American Society of Clinical Investigation and the American Association of Physicians.". Dr. Gharavi is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Focal Segmental Glomerulosclerosis, Nephrotic Syndrome, and Kidney Transplant.

Dr. Radhakrishnan is Professor of Medicine at Columbia University Medical Center. He is the Director of Clinical Services of the Nephrology Division. His clinical and research interests are the in the therapy of chronic kidney disease (including glomerular diseases and lupus kidney disease), hypertension and intensive care nephrology.He is a co-director of the hypertension center of Columbia UniverstiyHe is a fellow of the American Society of Nephrology and National Kidney Foundation. His commitment to medical education and patient care is exemplified by his numerous teaching awards and his inclusion in the Who's Who among America's Teachers & Educators, America's Best Doctors and Castle Connolly's Top Doctor. Dr. Radhakrishnan is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Focal Segmental Glomerulosclerosis, Glomerulonephritis, IgA Nephropathy, Chronic Kidney Disease, and Kidney Transplant.

Elie El is a Nephrologist in Staten Island, New York. Dr. El is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Failure, High Potassium Level, and Kidney Transplant.

Jordan Rosenstock is a Nephrologist in New York, New York. Dr. Rosenstock is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Chronic Kidney Disease, Glomerulonephritis, Acute Kidney Failure, and Nephrotic Syndrome.

Krzysztof Kiryluk is a Nephrologist in New York, New York. Dr. Kiryluk is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Focal Segmental Glomerulosclerosis, Membranous Nephropathy, and Kidney Transplant. Dr. Kiryluk is currently accepting new patients.

Frank Cortazar is an Internal Medicine specialist and a Nephrologist in Albany, New York. Dr. Cortazar has been practicing medicine for over 15 years and is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Glomerulonephritis, Granulomatosis with Polyangiitis, Membranous Nephropathy, Minimal Change Disease, and Kidney Transplant. Dr. Cortazar is currently accepting new patients.

Gerald Appel is an Internal Medicine provider in Tarrytown, New York. Dr. Appel is rated as a Distinguished provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Glomerulonephritis, IgA Nephropathy, Alport Syndrome, Kidney Transplant, and Nephrectomy.

Edward Epstein is a Nephrologist in Kew Gardens, New York. Dr. Epstein is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Minimal Change Disease, and High Potassium Level.

Jonathan Lin is an Internal Medicine provider in New York, New York. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Minimal Change Disease, and Acute Kidney Failure. Dr. Lin is currently accepting new patients.

Yaakov Liss is a Nephrologist in Fishkill, New York. Dr. Liss is rated as an Advanced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Nephrosclerosis, and Renovascular Hypertension.

Rimda Wanchoo is a Nephrologist in Great Neck, New York. Dr. Wanchoo is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Interstitial Nephritis, Low Sodium Level, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and Kidney Transplant.

Nupur Uppal is a Nephrologist in Great Neck, New York. Dr. Uppal is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are Acute Tubular Necrosis, Magnesium Deficiency, Interstitial Nephritis, Low Sodium Level, and Parathyroidectomy.

Dr. Joshua Schwimmer is a nephrologist doctor, a kidney and blood pressure specialist an based in Midtown Manhattan, NYC. With over 15 years of clinical experience in nephrology and general medicine, Dr. Schwimmer receives outstanding reviews from patients of all ages. In 2014, Dr. Schwimmer was recruited to join the full-time medical staff of Lenox Hill Hospital and Northwell Health Physician Partners. In practice with Dr. Mark Gardenswartz, Dr. Schwimmer sees patients at his East 59th Street office and hospitalized patients at Lenox Hill Hospital. As a doctor's; Dr. Schwimmer is trusted to provide care to many physicians and their families. As a believer in using technology to improve health care, he offers all patients free, secure communication by email. An award-winning physician-teacher, Dr. Schwimmer trained with Dr. Gerald Appel at New York-Presbyterian Hospital and the Columbia University College of Physicians & Surgeons, Strong Memorial Hospital, and the University of Rochester Medical Center. Prior to being recruited by Lenox Hill Hospital and Northwell Health, he has held appointments on the faculty of the Mount Sinai Medical Center, the Columbia University Medical Center, and the NYU School of Medicine, and he has published more than 25 scientific papers, abstracts, and book chapters. Dr. Schwimmer is a fellow of the American College of Physicians and the American Society of Nephrology. Dr. Schwimmer is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. His top areas of expertise are Acute Kidney Failure, Chronic Kidney Disease, High Potassium Level, and Hypertension.

Suzanne El is a Nephrologist in Staten Island, New York. Dr. El is rated as an Experienced provider by MediFind in the treatment of Minimal Change Disease. Her top areas of expertise are End-Stage Renal Disease (ESRD), Acute Kidney Failure, Chronic Kidney Disease, and Necrosis.